Ohi Y - Search Results

1

Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.

Sagara Y, Ohi Y, Matsukata A, Yotsumoto D, Baba S, Tamada S, Sagara Y, Matsuyama Y, Ando M, Rai Y, Sagara Y. Sagara Y, et al. Among authors: ohi y. Breast Cancer. 2013 Apr;20(2):181-6. doi: 10.1007/s12282-011-0324-z. Epub 2011 Dec 28. Breast Cancer. 2013. PMID: 22203582

2

Rim enhancement of breast cancers on contrast-enhanced MR imaging: relationship with prognostic factors.

Jinguji M, Kajiya Y, Kamimura K, Nakajo M, Sagara Y, Takahama T, Ando M, Rai Y, Sagara Y, Ohi Y, Yoshida H. Jinguji M, et al. Among authors: ohi y. Breast Cancer. 2006;13(1):64-73. doi: 10.2325/jbcs.13.64. Breast Cancer. 2006. PMID: 16518064 Free article.

3

Adverse events and bone health during anastrozole therapy in postmenopausal Japanese breast cancer patients.

Sagara Y, Kosha S, Baba S, Dokiya F, Tamada S, Sagara Y, Matsuyama Y, Ohi Y, Ando M, Rai Y, Sagara Y, Douchi T. Sagara Y, et al. Among authors: ohi y. Breast Cancer. 2010 Jul;17(3):212-7. doi: 10.1007/s12282-009-0135-7. Epub 2009 Jun 13. Breast Cancer. 2010. PMID: 19526308

4

Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis.

Umekita Y, Ohi Y, Iwaya O, Souda M, Sagara Y, Tamada S, Yotsumoto D, Tanimoto A. Umekita Y, et al. Among authors: ohi y. Histopathology. 2018 Dec;73(6):916-922. doi: 10.1111/his.13718. Epub 2018 Sep 25. Histopathology. 2018. PMID: 30035819

5

Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer.

Ohi Y, Umekita Y, Sagara Y, Rai Y, Yotsumoto D, Matsukata A, Baba S, Tamada S, Matsuyama Y, Ando M, Sagara Y, Sasaki M, Tsuchimochi S, Tanimoto A, Sagara Y. Ohi Y, et al. Br J Cancer. 2012 Oct 9;107(8):1239-43. doi: 10.1038/bjc.2012.387. Epub 2012 Aug 28. Br J Cancer. 2012. PMID: 22929881 Free PMC article.

6

Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients.

Umekita Y, Ohi Y, Sagara Y, Yoshida H. Umekita Y, et al. Among authors: ohi y. Int J Cancer. 2002 Mar 20;98(3):415-8. doi: 10.1002/ijc.10151. Int J Cancer. 2002. PMID: 11920593

7

Clinical significance of occult micrometastases in axillary lymph nodes in "node-negative" breast cancer patients.

Umekita Y, Ohi Y, Sagara Y, Yoshida H. Umekita Y, et al. Among authors: ohi y. Jpn J Cancer Res. 2002 Jun;93(6):695-8. doi: 10.1111/j.1349-7006.2002.tb01308.x. Jpn J Cancer Res. 2002. PMID: 12079518 Free PMC article.

8

Expression of maspin predicts poor prognosis in breast-cancer patients.

Umekita Y, Ohi Y, Sagara Y, Yoshida H. Umekita Y, et al. Among authors: ohi y. Int J Cancer. 2002 Aug 1;100(4):452-5. doi: 10.1002/ijc.10500. Int J Cancer. 2002. PMID: 12115529

9

Expression of wild-type estrogen receptor beta protein in human breast cancer: specific correlation with HER2/neu overexpression.

Umekita Y, Souda M, Ohi Y, Sagara Y, Rai Y, Takahama T, Yoshida H. Umekita Y, et al. Among authors: ohi y. Pathol Int. 2006 Aug;56(8):423-7. doi: 10.1111/j.1440-1827.2006.01983.x. Pathol Int. 2006. PMID: 16872435

10

Expression of estrogen receptor alpha and progesterone receptor in normal human breast epithelium.

Umekita Y, Souda M, Ohi Y, Rai Y, Sagara Y, Sagara Y, Yoshida H. Umekita Y, et al. Among authors: ohi y. In Vivo. 2007 May-Jun;21(3):535-9. In Vivo. 2007. PMID: 17591366 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters